UAA Stock Goes For 5th Straight Earnings Win

UAA stock is sitting atop a number of key technical levels before earnings

by Josh Selway

Published on Feb 11, 2019 at 11:13 AM

Under Armour Inc (NYSE:UAA) stock jumped 27.7% the day after earnings back in October, part of its streak of four consecutive quarters of post-earnings gains, including a 17.4% pop this quarter last year. The shares will try to keep the ball rolling following the company's earnings release tomorrow morning, and the options market is predicting another huge swing, pricing in a 21% move for UAA stock.

Today the equity is trading up 0.6% at $20.87, holding a recent foothold atop the 50-day and 200-day moving averages, also near the site of its November low and mid-December bear gap. For reference, a 21% move to the upside would put the athletic apparel specialist around $25.30, past its 52-week high of $24.96 from Dec. 3. Such a move lower would have the stock right at $16.50, the site of its notable multi-month low from December.

uaa stock chart

Under Armour's Schaeffer's put/call open interest ratio (SOIR) comes in at 0.59, showing a strong tilt to calls over puts among near-term options traders. More telling still, this reading ranks in the lowest annual percentile, showing that such a heavy call-skew for options expiring within three months is extremely unusual.

Looking at some of the recent activity from speculators, the weekly 3/1 26.50-strike call saw the largest increase in open interest during the past 10 days, followed by the March 22.50 call and the February 21 call. Anyone who bought to open these contracts would be betting on UAA shares rising in the coming weeks.

Lastly, we'd note that most brokerage firms are still bearish on the equity, with 18 of 23 handing out "hold," "sell," or "strong sell" recommendations, and the average 12-month price target of $21.04 is right in line with current levels. Some analysts have begun to come around on Under Armour, however, and another strong earnings performance could spark even more bullish attention.

SAGE Therapeutics Stock Hot Ahead of Earnings
The drug name is scheduled to report on Tuesday
Bear Signal Flashing for This Healthcare Stock Before Earnings
At least four analysts have issued price-target cuts on the stock this week
Signal Says This Retail Stock's on Sale
The shares pulled back this week on news of a Levi Strauss IPO

Get Schaeffer's pre-market news bulletin every morning before the bell rings.
It's free to sign up.


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

IRA/401K Investment Guide: 2019 Stock Market Crash
Use gold to protect any IRA, 401(k), or retirement account from a looming financial crisis.
3 of Today's Worst Nasdaq Stocks
The stocks are sitting out today's rally in the broader equities market
2019 Rally Continues for Stock Market
The Nasdaq is eyeing its longest weekly win streak since 2016
How American Lithium Tech May Be Poised for 614% Growth
A new lithium technology could change the face of lithium production forever.